INTRODUCTION
For dairy cattle, supplementation of a limiting AA in a ruminally protected form can reduce the requirement for RUP and improve performance (Schwab, 1995) . Historically, several rumen-protected methionine products were commercially available; but until recently, rumen-protected lysine products were fewer due to greater cost of production and instability (Swanepoel et al., 2010) . Amos and Evans (1978) observed in vitro that only 5% of L-lysine-HCl escaped ruminal degradation. Velle et al. (1998) found that 16% of lysine escaped ruminal degradation at 8 h when lysine-HCl was administered ruminally. Robinson et al. (2006) estimated that the escape value of free lysine fed to early lactating dairy cows was 3.5%. These results demonstrate that ruminally protected forms of lysine are needed if substantial amounts of lysine are to be made available to the bovine intestine.
The calcium salt of hydroxymethyl lysine (HML) is a derivative of lysine produced by reacting lysine-HCl with formaldehyde in an aqueous solution of calcium hydroxide. It is suggested to be protected from ruminal degradation yet intestinally available after acidifi cation in the abomasum (Bertram et al., 1978) . Richardson (1976) fed HML to lambs and, based on responses in N retention, wool growth, and plasma lysine concentrations, concluded that HML provided bioavailable lysine to sheep. Kenna and Schwab (1981) evaluated HML for dairy cattle fed corn silage-based diets, but positive responses were not obtained; authors suggested that mixing the HML with acidic silage in the diet may have degraded HML prematurely.
Our objective was to assess the availability to ruminants of lysine from HML. Initial studies used an in vitro approach. Although the in vitro assay was effective for measuring degradation of unprotected lysine, it was unsuitable for assessing degradation of HML. Therefore, a feeding study was conducted with sheep to assess availability of lysine from HML using plasma lysine concentrations as the response criterion.
MATERIALS AND METHODS
Procedures for these experiments were approved by the Kansas State University Institutional Animal Care and Use Committee.
Manufacture of Hydroxymethyl Lysine
Hydroxymethyl lysine was manufactured in our laboratory by the reaction of 1 mol of lysine-HCl with 1.32 mol of formaldehyde in a 1-L aqueous solution containing 1 mol of Ca(OH) 2 (Bertram et al., 1978) . The aqueous solution of Ca(OH) 2 and lysine-HCl was stirred and heated to 40°C for 30 min and then cooled on ice to 15 or 25°C. Formaldehyde (37% wt/wt) was added dropwise during cooling of the aqueous solution of Ca(OH) 2 and lysine-HCl. The solution was stirred for 3 h, cooled with ice to 5°C, then fi ltered under suction using Whatman 54 hardened low-ash fi lter paper (24 cm), and rinsed with cold water. The product was dried at 55°C in a forced-air oven for 24 h, then dried under vacuum (-100 kPa) at 55°C for an additional 24 h. For HML1, formaldehyde was added at 15°C, whereas for HML2, formaldehyde was added at 25°C. The HML1 contained 12.88% N and HML2 contained 11.59% N. To produce HML for the in vivo study, formaldehyde was added at 15°C; this HML product contained 12.28% N.
Evaluation of Ruminal Degradation of Hydroxymethyl Lysine In Vitro
General Methods. A model similar to that described by Russell (2006) was used to evaluate ruminal degradation of HML in vitro. The model used: 1) a concentration of lysine (50 mM) that leads to ammonia concentrations that can be quantifi ed easily, 2) a 4:1 ratio of McDougall's buffer (McDougall, 1948) to rumen fl uid to allow complete degradation of lysine (Russell, 2006 reported that the addition of greater proportions of rumen fl uid reduced lysine degradation), 3) incubation times up to 48 h to allow time for extensive degradation of lysine, and 4) centrifuged ruminal fl uid so feed particles and protozoa were removed.
Ruminal fl uid was collected from 2 ruminally cannulated dairy cows fed a typical dairy diet (Table 1) . Ruminal fl uid was strained through 4 layers of cheesecloth into 2 separate insulated containers and transferred to the lab. The pH of the ruminal fl uids were 5.66 and 6.89 for Exp. 1 and 6.09 and 6.45 for Exp. 2. Ruminal fl uids were centrifuged at 150 × g for 5 min at 20°C, then 40 mL of McDougall's buffer, and 10 mL of ruminal fl uid supernatant were dispensed into 100-mL centrifuge tubes. Tubes were fl ushed with CO 2 and capped with a butyl rubber stopper fi tted with a Bunsen valve; then tubes were vortexed and kept in an incubator at 39°C. Samples were collected at 24 and 48 h by removing 1 mL from each tube and transferring to microcentrifuge tubes; samples were acidifi ed with 0.2 mL of 1 M HCl and frozen at -20°C for later analysis of ammonia. Ammonia was analyzed according to Broderick and Kang (1980) using an AutoAnalyzer (Technicon Analyzer II, Technicon Industrial Systems, Buffalo Grove, IL). Treatments were evaluated in duplicate in vitro tubes for each rumen fl uid donor.
In Vitro Degradation of Free Lysine, HML1, and HML2 (Exp. 1). Lysine-HCl and the 2 HML products were weighed in 100-mL centrifuge tubes to provide 50 mM lysine. Due to the alkaline nature of HML products, the pH of tubes containing HML products were 8. 84 of Ca(OH) 2 added were 26.5% of the weights of HML1 added; this was based on our observation that, to bring pH to 7, HML1-containing solutions of equal concentration (wt/vol) required 26.5% as much HCl as did Ca(OH) 2 -containing solutions. Tubes containing Ca(OH) 2 or HML were neutralized to pH 7.0 with additions of 1 M HCl after the addition of McDougall's buffer. Control tubes with only lysine were used, as were blank tubes with no lysine.
In vitro data were analyzed for repeated measures using the MIXED procedure (SAS Inst. Inc., Cary, NC) with a model that contained effects of inoculum donor, treatment, fermentation time, and treatment × time; time was the repeated measure, with fermentation tube the subject of the repeated observations. Means were separated using pairwise t-tests when the F-test was signifi cant (P < 0.05).
In Vivo Bioavailability of Hydroxymethyl Lysine to Sheep (Experiment 3)
Twelve mature Suffolk ewes (77.4 kg) were placed in a large, partially covered pen (6 × 12 m) at the sheep unit of Kansas State University. They were limit fed (1.6 kg/d, DM basis) a diet designed to meet or slightly exceed their maintenance requirements for energy and protein. Sheep were fed individually twice daily (0700 and 1900 h) for 3 consecutive 7-d periods. The diet was composed of 45.5% alfalfa hay, 44.7% rolled corn, 4.1% mechanically extracted soybean meal, 5.1% molasses, and 0.57% salt; by analysis, it contained 15.4% CP and 23.4% NDF (assayed with heat-stable amylase and expressed inclusive of ash) on a DM basis.
Individual feeding pens (46 cm wide × 1 m long) were within the large pen and sheep were excluded, except during feeding. At the time of feeding, sheep were allowed to enter an individual pen and feed was offered. Sheep were kept in individual feeding pens for 30 min at each feeding time. Sheep were trained to the feeding system 4 d before starting the experiment and they adapted well to the feeding system and routine. Water was available for ad libitum intake in the large pen.
The fi rst period was a control period with no lysine supplementation and blood samples were collected at the end of this period to serve as baseline measurements. The second and third periods were the treatment periods when sheep received the 4 treatments as presented in Table 2 ; each possible pair of the 4 lysine-containing treatments was represented in 2 sheep, with the order reversed between the 2 sheep assigned to the same pair of treatments. Diets were mixed with 14.2 and 28.4 g/d of a commercially available ruminally protected lysine (RPL; LysiPEARL, Kemin Industries, Inc., Des Moines, IA; 21% of product weight was intestinally available lysine as specifi ed by the manufacturer; Musser and Valdez, 2010) to provide 3 or 6 g/d of intestinally available lysine or with HML in amounts (4.68 and 9.36 g/d) that contained 3 or 6 of g/d of total lysine. Treatments were divided equally between the 2 daily meals and mixed completely with the diet.
All data from 1 sheep were excluded from the trial because of an inconsistent feeding pattern during the second period. For the 11 remaining sheep, orts never exceeded 8.9% of the offered diet and were not considered a contributor to animal response to treatment. On the fi nal day of each period, blood samples (10 mL) were collected by jugular venipuncture at 3 h after the morning feeding, using 20-gauge needles during manual restraint of the sheep. Blood samples were placed on ice directly after collection, transferred to the lab, then centrifuged at 1,000 × g for 15 min at 4°C. Plasma was transferred to microcentrifuge tubes and stored frozen at -20°C for later analysis of plasma AA by cation exchange HPLC with postcolumn o-phthalaldehyde derivatization and fl uorimetric quantifi cation (Beckman System Gold, Beckman, Palo Alto, CA), using norleucine as an internal standard.
Plasma AA concentrations were statistically analyzed for an incomplete block design with blocking based on sheep and period. The MIXED Procedure of SAS was used with treatment included as a fi xed effect and sheep and period included as random effects. Means were separated using linear and quadratic contrasts for HML and RPL when the treatment F-test demonstrated P < 0.1. Additionally, the plasma lysine concentrations were evaluated using a regression model with amounts of total lysine from HML and intestinally available lysine from RPL included as regression variables, and with animal and period included as random discrete variables. The slopes of the responses to HML and RPL were directly compared. 12 0 RPL-6 HML-3 1 0 = control; HML-3 = 3 g/d total lysine from hydroxymethyl lysine; HML-6 = 6 g/d total lysine from hydroxymethyl lysine; RPL-3 = 3 g/d intestinally available lysine from rumen-protected lysine; RPL-6 = 6 g/d intestinally available lysine from rumen-protected lysine.
2 Data from sheep 10 were excluded from analysis.
RESULTS

In Vitro Degradation of Free Lysine, Hydroxymethyl Lysine 1, and Hydroxymethyl Lysine 2 (Experiment 1)
Ammonia concentrations produced from in vitro fermentation of pure lysine or HML products (Table 3) were affected (P < 0.05) by lysine source, incubation time, and the interaction of lysine source with incubation time. No differences were found between ammonia concentrations produced from HML1 and HML2, compared with blank tubes (no lysine) at either 24 or 48 h. At 24 h, free lysine led to more ammonia than the blank and ammonia produced from free lysine at 48 h was strikingly greater (P < 0.01) than that from HML1 or HML2.
Effect of Hydroxymethyl Lysine and Ca(OH) 2 on In Vitro Degradation of Free Lysine (Experiment 2)
Table 4 presents the ammonia concentrations produced from in vitro fermentation of 25 mM lysine incubated with graded amounts of Ca(OH) 2 or HML1. Fermentation of lysine alone led to increases (P < 0.01) in ammonia at 48 h but not at 24 h. Addition of HML at all levels tested (as low as 6.25 mM) completely inhibited ammonia production from free lysine. In contrast, increasing Ca(OH) 2 did not affect ammonia production.
In Vivo Bioavailability of Hydroxymethyl Lysine to Sheep (Experiment 3)
Plasma lysine concentrations (Table 5) increased linearly with lysine supplemented as either RPL (P = 0.05) or HML (P = 0.06), but quadratic effects were not observed (P > 0.9). Similarly, plasma lysine expressed as a percentage of total AA increased linearly with supplementation of either RPL (P < 0.01) or HML (P = 0.02), with no quadratic effects observed (P ≥ 0.26).
Based on the linear increases in plasma lysine, to better quantify responses to the 2 lysine sources, plasma lysine concentrations were regressed against the amounts of lysine supplemented either from HML or RPL (Figure 1) . The linear increases in plasma lysine were highly signifi cant for both lysine sources and no statistical difference was observed (P = 0.78) between the slopes of the regression lines for HML and RPL (Figure 1) . The relative bioavailability of lysine from HML compared with RPL was 94%, calculated by dividing the slope for HML (6.25) by that for RPL (6.64). Because the amounts of supplemental lysine from RPL were based on amounts of intestinally available (metabolizable) lysine, the 94% availability for lysine in HML can be considered true intestinal availability for the total lysine in HML. Because the slopes were not different from each other, the estimated bioavailability of 94% was not statistically different from 100%. Similar conclusions were drawn when plasma lysine as a percentage of total plasma AA was regressed against lysine intake (data not shown), although the bioavailability was only 81% (not different from 100%).
Among the AA besides lysine, only taurine demonstrated treatment responses. Plasma taurine concentrations increased linearly with supplementation of lysine from either HML (P = 0.01) or RPL (P = 0.02). The reason for this response in plasma taurine is unknown, but the consistency between HML and RPL suggests that the effect is real. Treatment had no effect on plasma concentrations of α-amino adipic acid (P = 0.70). 
DISCUSSION
In Vitro Degradation of Free Lysine, Hydroxymethyl Lysine 1, and Hydroxymethyl Lysine 2 (Experiment 1)
Concentrations of lysine in the in vitro system, based on the model of Russell (2006) , are much greater than would be observed in vivo; this allows release of ammonia in concentrations that can be easily measured without substantial interference from background concentrations of ammonia or from bacterial utilization of ammonia. However, incubation periods longer than in vivo retention times are needed for extensive degradation of the lysine concentrations used. Thus, although the model is useful for evaluating degradation of lysine, rates of degradation do not refl ect those observed when concentrations are close to those observed in vivo (Velle et al., 1998; Robinson et al., 2006) .
The high degradability of free lysine at 48 h is in accordance with the results of Russell (2005) , although the ammonia released in this assay at 48 h represented only about one-half of the N provided as free lysine. The low degradabilities of HML1 and HML2 suggested that the lysine in HML1 and HML2 was well protected from ruminal degradation; however, the possibility existed (and was subsequently verifi ed) that low ammonia production from HML refl ected an inhibitory effect of the HML products on ruminal microbes such that microbial function was impaired, thereby limiting lysine degradation.
Effect of Hydroxymethyl Lysine and Ca(OH) 2 on In Vitro Degradation of Free Lysine (Experiment 2)
Data clearly demonstrated that HML inhibited lysine degradation in vitro when added in concentrations as low as 6.25 mM; thus, the in vitro assay could not be considered effective for assessing ruminal degradation of HML.
The large amount of calcium contained in HML or our neutralization of the alkaline HML with HCl were considered potential mechanisms for the inhibition of lysine degradation in vitro. The increased concentration of calcium might have antimicrobial effects or might inhibit lysine transport. Nakamura et al. (1996) reported that increased concentrations of calcium (5 to 50 mM) had an antimicrobial effect on Selenomonas ruminantium HD-4, but additions of calcium up to 35 mM did not inhibit lysine degradation in our study. In fact, it led to numeric increases in ammonia production. Thus, the inhibition of lysine catabolism by HML cannot be attributed to the Total AA 2,104 2,382 2,442 2,385 2,359 297 1 HML-3 = 3 g/d total lysine from hydroxymethyl lysine; HML-6 = 6 g/d total lysine from hydroxymethyl lysine; RPL-3 = 3 g/d intestinally available lysine from rumen-protected lysine; RPL-6 = 6 g/d intestinally available lysine from rumen-protected lysine.
2 Largest SEM among all treatments.
3 Linear effect of RPL (P ≤ 0.05). 4 Linear effect of HML (P = 0.06).
5 Linear effect of HML (P < 0.05).
Figure 1.
Effect of hydroxymethyl lysine (HML) and rumen-protected lysine (RPL) on plasma lysine concentrations of sheep (Exp. 3).The RPL was provided as amounts of available lysine, whereas HML was provided in amounts of total lysine. Both sources increased plasma lysine concentrations (P < 0.01) and increases were similar between products (P = 0.78). calcium content of HML or our neutralization procedures. Although we cannot explain the inhibition of microbial activity by HML, trace amounts of formaldehyde remaining from the production of HML may have been great enough to be toxic under our in vitro conditions. It is also possible that HML itself directly inhibited microbial growth, enzymes involved in lysine degradation, or both. Regardless of the reason, the in vitro assay was inadequate to assess ruminal degradation of HML and an in vivo approach was therefore used.
In Vivo Bioavailability of Hydroxymethyl Lysine to Sheep (Experiment 3)
Our goal was to provide the sheep with a diet that was not limiting in lysine so, when sheep received supplemental lysine, the intestinally absorbed lysine would raise plasma concentrations with linear responses. The 2 levels of lysine that we used were based on previous work (Nimrick et al., 1970; Brookes et al., 1973) in which linear increases in plasma concentration of lysine were observed over the amounts supplemented. The RPL served as a standard product with known lysine availability so we could generate a standard curve to measure lysine availability of HML. The plasma lysine responses to HML refl ect the ability of the product both to protect lysine from ruminal microbial degradation and provide lysine to the intestine in an absorbable form. The high bioavailability of HML (94%) indicates that it was well protected from ruminal degradation and HML is acid labile, such that the lysine is available for intestinal absorption.
In our study, blood samples were collected at 3 h after feeding. The timing of lysine delivery to the intestine could differ between HML and RPL because passage rates from the rumen could differ between the products, and because ruminal protection of lysine in RPL could be time dependent. Thus, it is possible that slightly different estimates of lysine bioavailability from HML might have been derived if blood had been sampled either at multiple time points or a time different from 3 h after feeding.
Because α-amino adipic acid is an intermediate in lysine catabolism (Fellows and Lewis, 1973) , increases in plasma concentrations of α-amino adipic acid would not be surprising in response to supplementation of excess lysine; however, the lack of change in plasma concentrations of α-amino adipic acid suggests that either α-amino adipic acid is not an important intermediate in lysine catabolism by sheep, the amounts of lysine supplemented were not large enough to signifi cantly impact fl ux through this intermediate, or catabolism of α-amino adipic acid is rapid enough to prevent its accumulation. Rulquin and Kowalczyk (2003) proposed use of calibration curves of plasma AA (methionine or lysine) in response to abomasal infusion of graded amounts of methionine or lysine to lactating cows to quantitatively measure the effi cacy of protected AA. They suggested that plasma AA can be more accurate than in vivo studies with intestinally cannulated animals or in vitro methods of assessment. To verify their method, they used protected AA with known availability to plot against the regression lines generated from infused AA. They reported that the method was reliable for infused methionine. Although they obtained a linear response with infused lysine, slopes of the regression lines of lysine concentration differed among the 3 cows they used. The researchers attributed this to the cows producing different amounts of milk protein, which affected lysine concentration in the blood. We used adult, nonlactating, nonpregnant ewes with low AA requirements to ensure that the basal absorbed lysine supply was more than the ewes' requirements, thereby reducing variation among animals. We also used 12 ewes to account for animal-to-animal variation. Rulquin and Kowalczyk (2003) also reported that instead of using cannulated cows and postruminally infused AA, rumen-protected AA products with known availability could produce calibration curves for reliable estimation of availability. For our experiment, the availability of lysine from the standard RPL was provided by the manufacturer. If the availability from RPL is incorrectly estimated, this will also lead to incorrect estimation of HML availability. The increases in plasma lysine in response to RPL supplementation were similar to those observed by Nimrick et al. (1970) and Brookes et al. (1973) , when lysine was provided postruminally to sheep, suggesting that the availability of lysine from RPL was near the value provided by the manufacturer.
There are alternative research approaches that would yield more defi nitive estimation of lysine availability from HML. Most notably, direct provision of lysine to the small intestine would be a more defi nitive standard for evaluation than use of RPL. However, provision of lysine directly to the small intestine requires use of animals surgically cannulated in the abomasum or duodenum. Based on ethical considerations, we preferred to generate a general estimate of HML availability. Richardson (1976) studied the effect of feeding free lysine and methionine, hydroxymethyl methionine, and a combination of hydroxymethyl methionine and HML to wether lambs on N retention, wool growth, feed intake, ADG, and feed effi ciency. The combination of hydroxymethyl methionine and HML improved N retention, wool growth, daily BW gain, and feed intake compared with control and other treatments. In contrast, when Kenna and Schwab (1981) evaluated the effect of supplementing calcium salts of hydroxymethyl methionine and di-HML, either alone or in combination, to lactating dairy cattle fed a corn silage-based diet (67% corn silage, 33% concentrate, and 2.2 kg/d of hay), positive responses were not observed for milk production and plasma concentrations of lysine and methionine were not altered compared with the basal diet. The authors suggested that the lack of response could be a result of the release of the free AA from their protected form as a result of mixing them with an acidic diet (corn silage). Therefore, the acidity of dietary ingredients, such as silages, should be considered when mixing with HML because lysine might be released before feeding.
Conclusion
Based on increases in plasma lysine concentration when HML was included in the diet, HML was determined to be a source of bioavailable lysine for ruminants. The bioavailability of lysine in HML was estimated to be 94% relative to a commercially available product of rumen-protected lysine. Our evaluation was conducted using a dry, nonacidic diet; bioavailability could be less if the product was mixed with an acidic diet.
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